Guardado en:
Detalles Bibliográficos
Autores principales: Wataru Kudo, Keita Terui, Katsuhiro Nishimura, Daisuke Katsumi, Ryoya Furugane, Ayako Takenouchi, Shugo Komatsu, Satoru Oita, Yunosuke Kawaguchi, Tomoro Hishiki
Formato: Artículo Open Access
Publicado: Wiley 2025
Materias:
Acceso en línea:https://onlinelibrary.wiley.com/doi/10.1002/pbc.32082
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1867003113092677632
author Wataru Kudo
Keita Terui
Katsuhiro Nishimura
Daisuke Katsumi
Ryoya Furugane
Ayako Takenouchi
Shugo Komatsu
Satoru Oita
Yunosuke Kawaguchi
Tomoro Hishiki
author_facet Wataru Kudo
Keita Terui
Katsuhiro Nishimura
Daisuke Katsumi
Ryoya Furugane
Ayako Takenouchi
Shugo Komatsu
Satoru Oita
Yunosuke Kawaguchi
Tomoro Hishiki
Wataru Kudo
Keita Terui
Katsuhiro Nishimura
Daisuke Katsumi
Ryoya Furugane
Ayako Takenouchi
Shugo Komatsu
Satoru Oita
Yunosuke Kawaguchi
Tomoro Hishiki
collection Wiley Open Access
contents Dual Use of Skeletal Muscle Index and Body Mass Index Measured at the Time of Diagnosis Predicts Prognosis in Children With Malignant Solid Tumors: A Single‐Center Retrospective Study Wataru Kudo Keita Terui Katsuhiro Nishimura Daisuke Katsumi Ryoya Furugane Ayako Takenouchi Shugo Komatsu Satoru Oita Yunosuke Kawaguchi Tomoro Hishiki Pediatric Blood & Cancer ABSTRACT Background Sarcopenia, a progressive muscle‐wasting disorder, is increasingly being recognized in childhood cancers. While skeletal muscle index (SMI) is commonly used to assess sarcopenia, we investigated the combined utility of SMI and body mass index (BMI) in predicting the prognosis of children with malignant solid tumors. Methods The BMI and SMI of 119 children with different types of malignant solid tumors were analyzed. Computed tomography and height at the time of diagnosis were used to determine the SMI. SMI and BMI were standardized using reference values. Cluster and survival time analyses were conducted to identify subpopulations. Results Cluster analysis performed using z ‐scores for SMI and BMI yielded four clusters: Cluster 1 had high z ‐scores for both indices; Cluster 2 had average z ‐scores for both indices; Cluster 3 had low z ‐scores for SMI and average z ‐scores for BMI; and Cluster 4 had low z ‐scores for both indices. Cluster classification was an independent prognostic factor for both event‐free survival (hazard ratio 1.56; 95% confidence interval: 1.09–2.25) and overall survival (hazard ratio 1.70; 95% confidence interval: 1.10–2.64) after combining age and metastasis. Cluster 1 had low metastasis prevalence and a favorable prognosis, whereas Cluster 4 exhibited a poorer prognosis. Conclusion The potential prognoses of the four distinct patient clusters based on the z ‐scores for SMI and BMI at the time of diagnosis were determined. The dual use of SMI and BMI may facilitate the identification of children with malignant solid tumors who are at a high risk of poor outcomes. 10.1002/pbc.32082 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/pbc.32082
format Artículo Open Access
id wiley_oa_10_1002_pbc_32082
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Dual Use of Skeletal Muscle Index and Body Mass Index Measured at the Time of Diagnosis Predicts Prognosis in Children With Malignant Solid Tumors: A Single‐Center Retrospective Study
Wataru Kudo
Keita Terui
Katsuhiro Nishimura
Daisuke Katsumi
Ryoya Furugane
Ayako Takenouchi
Shugo Komatsu
Satoru Oita
Yunosuke Kawaguchi
Tomoro Hishiki
Pediatric Blood & Cancer
Dual Use of Skeletal Muscle Index and Body Mass Index Measured at the Time of Diagnosis Predicts Prognosis in Children With Malignant Solid Tumors: A Single‐Center Retrospective Study Wataru Kudo Keita Terui Katsuhiro Nishimura Daisuke Katsumi Ryoya Furugane Ayako Takenouchi Shugo Komatsu Satoru Oita Yunosuke Kawaguchi Tomoro Hishiki Pediatric Blood & Cancer ABSTRACT Background Sarcopenia, a progressive muscle‐wasting disorder, is increasingly being recognized in childhood cancers. While skeletal muscle index (SMI) is commonly used to assess sarcopenia, we investigated the combined utility of SMI and body mass index (BMI) in predicting the prognosis of children with malignant solid tumors. Methods The BMI and SMI of 119 children with different types of malignant solid tumors were analyzed. Computed tomography and height at the time of diagnosis were used to determine the SMI. SMI and BMI were standardized using reference values. Cluster and survival time analyses were conducted to identify subpopulations. Results Cluster analysis performed using z ‐scores for SMI and BMI yielded four clusters: Cluster 1 had high z ‐scores for both indices; Cluster 2 had average z ‐scores for both indices; Cluster 3 had low z ‐scores for SMI and average z ‐scores for BMI; and Cluster 4 had low z ‐scores for both indices. Cluster classification was an independent prognostic factor for both event‐free survival (hazard ratio 1.56; 95% confidence interval: 1.09–2.25) and overall survival (hazard ratio 1.70; 95% confidence interval: 1.10–2.64) after combining age and metastasis. Cluster 1 had low metastasis prevalence and a favorable prognosis, whereas Cluster 4 exhibited a poorer prognosis. Conclusion The potential prognoses of the four distinct patient clusters based on the z ‐scores for SMI and BMI at the time of diagnosis were determined. The dual use of SMI and BMI may facilitate the identification of children with malignant solid tumors who are at a high risk of poor outcomes. 10.1002/pbc.32082 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Dual Use of Skeletal Muscle Index and Body Mass Index Measured at the Time of Diagnosis Predicts Prognosis in Children With Malignant Solid Tumors: A Single‐Center Retrospective Study
topic Pediatric Blood & Cancer
url https://onlinelibrary.wiley.com/doi/10.1002/pbc.32082